Trulicity 1.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FKZWU
- Awardee
-
Dakota Drug, Inc. UEI H544BCGUKW64
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,820
Award facts
- Contract value 100% obligated
- $1,820.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Anoka, MN, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,820.43 to Dakota Drug, Inc. for the supply of Trulicity 1.5 mg/0.5 mL pens on June 18, 2025, with completion targeted for June 20, 2025. This delivery order is issued under Dakota Drug's larger Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00 through December 31, 2025. The award carries no set-aside designation and is structured as a firm fixed-price contract with performance at Dakota Drug's Anoka, Minnesota facility. Trulicity is a diabetes management medication frequently required by military medical facilities to support U.S. Armed Forces healthcare operations.
Dakota Drug, Inc., a self-certified small disadvantaged business registered in SAM.gov since 2001, serves as a critical supplier of pharmaceutical and medical products to federal defense agencies. The company's extensive portfolio under its DLA master contract encompasses diverse medications including diabetes management products, respiratory treatments, pain management drugs, cardiovascular medications, and vaccines. This delivery order represents one of numerous orders executed under the broader IDC, which positions Dakota Drug as a strategic vendor within the military medical supply chain and enables efficient distribution of essential pharmaceuticals to defense healthcare facilities nationwide.
Quick answers
Who was awarded contract SPE2DB25FKZWU?
SPE2DB25FKZWU was awarded to Dakota Drug, Inc. by Defense Logistics Agency (Department of Defense) on June 18, 2025.
How much is contract SPE2DB25FKZWU worth?
The government has obligated $1,820 on SPE2DB25FKZWU.
Is contract SPE2DB25FKZWU an order under another contract?
Yes. SPE2DB25FKZWU is a delivery order under SPE2DB24D8001, an indefinite delivery contract.
Was contract SPE2DB25FKZWU competed?
The extent of competition for SPE2DB25FKZWU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award